Pramlintide Acetate
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Pramlintide Acetate is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 16, 2005. In 2024, Medicare Part D spent $3 million on Pramlintide Acetate across 1,579 claims for 377 beneficiaries.
Pramlintide Acetate is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $217.52 to $330.95 per ML — a 52% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$217.52 – $330.95
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing PRAMLINTIDE ACETATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SYMLINPEN 60 PEN INJECTOR | $330.9522 per ML | — |
SYMLINPEN 120 PEN INJECTOR | $217.5214 per ML | — |
Frequently Asked Questions
What is Pramlintide Acetate used to treat?
Pramlintide Acetate is used to treat type 1 diabetes mellitus and type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Pramlintide Acetate?
In 2024, Medicare Part D spent $3 million on Pramlintide Acetate across 1,579 claims for 377 beneficiaries.
How many Pramlintide Acetate products are on the market?
The Pramlintide Acetate drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Pramlintide Acetate?
NADAC reference prices for Pramlintide Acetate range from $217.5214 to $330.9522 per ML — a 52% difference between cheapest and most expensive.
Which manufacturers make Pramlintide Acetate?
1 manufacturer lists Pramlintide Acetate in NADAC. Ranked by number of NDCs, the largest are AstraZeneca Pharmaceuticals LP (2).